Skip to main content
Commission and its priorities
Policies, information and services
Home - European Commission
English
en
Dialog
Select your language
Български
Čeština
Dansk
Deutsch
Eesti
Ελληνικά
English
Español
Français
Hrvatski
Gaeilge
Italiano
Latviešu
Lietuvių
Magyar
Malti
Nederlands
Polski
Português
Română
Suomi
Slovenčina
Slovenščina
Svenska
Close
Search this website
Search
European Commission
Live, work, travel in the EU
Public Health
Medicinal products
Medicinal products
All topics
Medicinal products
EU action on health
EU Health Policy
State of Health in the EU
Funding
International cooperation
Indicators and data
Improving health systems
Cross-border healthcare
European Reference Networks
eHealth : Digital health and care
Health technology assessment
Health workforce
Health systems performance assessment
Expert panel
Promoting good health
Tobacco
Nutrition and physical activity
Alcohol
Social determinants
Pharmaceuticals and substances of human origin
Medicinal products
European Medicines Agency (EMA)
Blood, tissues, cells and organs
Diseases and health threats
Crisis preparedness and response
Communicable diseases
European Centre for Disease Prevention and Control (ECDC)
Vaccination
Antimicrobial resistance
Non-communicable diseases
Risk assessment
Scientific committees
Endocrine disruptors
Endocrine disruptors
Biocides
Biocides
Projects
Back to general list
Select a year
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
Search for a project
EU action on health
EU Health Policy
State of Health in the EU
Funding
International cooperation
Indicators and data
Improving health systems
Cross-border healthcare
European Reference Networks
eHealth : Digital health and care
Health technology assessment
Health workforce
Health systems performance assessment
Expert panel
Promoting good health
Tobacco
Nutrition and physical activity
Alcohol
Social determinants
Pharmaceuticals and substances of human origin
Medicinal products
European Medicines Agency (EMA)
Blood, tissues, cells and organs
Diseases and health threats
Crisis preparedness and response
Communicable diseases
European Centre for Disease Prevention and Control (ECDC)
Vaccination
Antimicrobial resistance
Non-communicable diseases
Risk assessment
Scientific committees
Endocrine disruptors
Endocrine disruptors
Biocides
Biocides
/health/file/state_healthpng_enstate_health.png
/health/file/brexit_notices3jpg_enbrexit_notices3.jpg
e-newsletter
e-newsletter
e-newsletter
Thu, 06/06/2019
European Semester: Health reforms need to continue
Latest updates
The Netherlands and Luxembourg to also benefit from EU-US mutual recognition agreement for inspections
Released
11 June 2019
List of fields contained in the "EudraCT" clinical trials database to be made public, in accordance with Article 57(2) of Regulation (EC) No 726/2004 and its implementing guideline 2008/C168/02
Released
06 June 2019
List of fields to be made public from EudraCT for Paediatric Clinical Trials in accordance with Article 41 of Regulation (EC) No 1901/2006 and its implementing guideline 2009/C28/01
Released
06 June 2019
Follow us on twitter
More
Highlights
Conference “Medicines for rare diseases and children: learning from the past, looking to the future” (Brussels, 17 June 2019)
Question and Answers on the interplay between the Clinical Trials Regulation and the General Data Protection Regulation
Information – Withdrawal of the United Kingdom and EU rules on batch testing of medicinal products
Related information
Press material
Videos
Eurobarometers
Events
Consultations
Publications
